Key result
hMPV M2-2 expression induced 1,473 alternative splicing events across 1,073 host genes, and CRISPR knockout of target genes STRAP and TANC2 reduced viral titers by 9-fold and 33-fold, respectively.
Why the study?
Human metapneumovirus is a widespread respiratory pathogen, but the mechanisms by which it modulates host gene expression to facilitate replication remain incompletely characterized.
Answers are grounded in this paper and cite their sources.
This preclinical study demonstrates that the hMPV M2-2 protein hijacks host nuclear splicing factors (hnRNP H1, M, and U) to reprogram alternative splicing of STRAP and TANC2, identifying the virus–spliceosome interface as a potential antiviral therapeutic target.
Human metapneumovirus (hMPV) is a widespread and prevalent respiratory pathogen, yet the mechanisms by which hMPV modulates host gene expression to facilitate replication remain incompletely characterized. Here, we systematically profiled hMPV–host protein–protein interactions by affinity purification-mass spectrometry and assessed their impact on host mRNA splicing using RNA sequencing, complemented by genetic perturbation, protein interaction assays, and fluorescence microscopy–based subcellular localization and colocalization analyses. Among the viral proteins analyzed, the regulatory protein M2-2 was found to directly interact with multiple splicing factors. Transcriptomic analysis revealed that M2-2 triggers extensive changes in alternative splicing across host genes, notably affecting STRAP and TANC2 , both of which exhibit distinctsplicing patterns during hMPV infection. Knockdown of M2-2 using short hairpin RNA (shRNA) during hMPV infection reversed M2-2–driven changes in the splicing patterns of STRAP and TANC2 , confirming its regulatory role. Functional knockout of STRAP or TANC2 significantly impaired viral replication, indicating that the M2-2–favored isoforms are required for efficient viral propagation. Collectively, our findings demonstrate a novel mechanism by which hMPV M2-2 hijacks the host splicing machinery to reprogram key factors that facilitate viral replication. This extends the functional repertoire of M2-2 and highlights the virus–spliceosome interface as a potential therapeutic target for anti-hMPV intervention. • Human metapneumovirus M2-2 recruits heterogeneous nuclear ribonucleoproteins (hnRNPs) to hijack the host splicing machinery. • hMPV M2-2 reprograms the alternative splicing of the cellular genes STRAP and TANC2 to favor viral replication. • Targeting the M2-2–spliceosome axis represents a promising therapeutic strategy against hMPV.
No takes yet. Share an insight, caveat, or question.
Guo et al. (2026) studied Human metapneumovirus (hMPV) infection (in vitro cell culture models). hMPV M2-2 protein expression, shRNA knockdown of M2-2, and CRISPR/Cas9 knockout of host genes STRAP and TANC2 vs. Empty vector control, scramble shRNA (shScramble), control siRNA, or wild-type non-knockout cells was evaluated on Host mRNA alternative splicing events (ΔPSI ≥ 30%) and hMPV viral replication (F protein expression and viral plaque titers) (p=<0.0001). hMPV M2-2 expression induced 1,473 alternative splicing events across 1,073 host genes, and CRISPR knockout of target genes STRAP and TANC2 reduced viral titers by 9-fold and 33-fold, respectively.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: